Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
J B Chemicals & Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:506943NSE Symbol: JBCHEPHARMP/E(TTM):40.54
ISIN Demat:INE572A01036Div & Yield %:0.85EPS(TTM):44.97
Book Value(Rs):237.6592049Market Cap ( Cr.):28558.58Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 3722.923298.642884.162189.881892.001640.74
Excise Duty0.000.000.000.000.000.00
Net Sales3722.923298.642884.162189.881892.001640.74
Other Income 34.7434.678.6538.61115.9247.13
Stock Adjustments -15.5349.2227.4825.5715.70-2.53
Total Income3742.133382.532920.292254.062023.621685.34
EXPENDITURE :      
Raw Materials 1236.701158.291064.21769.27641.46566.61
Power & Fuel Cost83.8387.9591.4471.3762.6061.54
Employee Cost 646.79565.38499.95399.06305.98293.78
Other Manufacturing Expenses 143.79120.93106.1397.3684.6977.06
Selling and Administration Expenses 491.43446.93394.90305.91204.68205.02
Miscellaneous Expenses 86.9288.9690.3363.5855.9673.75
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure2689.462468.442246.951706.541355.371277.77
Operating Profit1052.68914.09673.34547.52668.25407.59
Interest 9.1240.5234.314.957.192.94
Gross Profit1043.56873.57639.03542.57661.06404.65
Depreciation166.45135.24111.9971.2867.3665.09
Profit Before Tax877.11738.33527.04471.29593.70339.56
Tax191.69145.4983.35122.50137.5082.02
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax32.8849.4954.80-12.219.12-10.60
Reported Net Profit652.54543.36388.89361.00447.08268.14
Extraordinary Items 20.0011.702.9227.7546.9712.62
Adjusted Net Profit632.54531.66385.97333.25400.11255.52
Adjst. below Net Profit -4.43-3.710.130.07-12.50-5.06
P & L Balance brought forward2452.822070.161808.731575.181214.011092.46
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 237.04156.99127.59127.5273.42141.53
P & L Balance carried down2863.892452.822070.161808.731575.181214.01
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1550.001225.00887.50825.00825.00550.00
Earnings Per Share-Unit Curr41.9235.0150.2646.7157.8534.70
Earnings Per Share(Adj)-Unit Curr41.9235.0125.1323.3628.9317.35
Book Value-Unit Curr216.94185.98315.65272.21233.75187.02